HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism
HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism
复制标题
DOI:
10.1038/nsmb.2223
复制
发表时间:
2012-02-01
影响因子:
16.8
通讯作者:
Arnold, Eddy
中科院分区:
文献类型:
--
作者:
Das, Kalyan;Martinez, Sergio E.;Arnold, Eddy
Combinations of nucleoside and non-nucleoside inhibitors (NNRTIs) of HIV-1 reverse transcriptase (RI) are widely used in anti-AIDS therapies. Five NNRTIs, including nevirapine, are clinical drugs; however, the molecular mechanism of inhibition by NNRTIs is not clear. We determined the crystal structures of RT-DNA-nevirapine, RI-DNA, and RT-DNA-AZT-triphosphate complexes at 2.85-, 2.70- and 2.80-angstrom resolution, respectively. The RI-DNA complex in the crystal could bind nevirapine or AZT-triphosphate but not both. Binding of nevirapine led to opening of the NNRTI-binding pocket. The pocket formation caused shifting of the 3' end of the DNA primer by similar to 5.5 angstrom away from its polymerase active site position. Nucleic acid interactions with fingers and palm subdomains were reduced, the dNTP-binding pocket was distorted and the thumb opened up. The structures elucidate complementary roles of nucleoside and non-nucleoside inhibitors in inhibiting RT.